From the Premier, Inc. blog:
“COVID-19 interrupted many organizations’ daily operations – including, most likely, a reduced or suspended cadence of regulatory readiness planning.
“Any regulatory readiness that’s been on pause, however, will need to pick up quickly. The Joint Commission announced it will begin resuming regular surveys and reviews this month.
“Healthcare leaders need to ensure that their plans to resume routine operations, including reopening services that were closed or significantly reduced, take into account strategies to re-institute regulatory compliance activities and waiver reversal. Failure to do so could risk the loss of Medicare and third-party payer reimbursements…”